Concepedia

V A Miller

VA

3

Publications

264

Citations

3

H-Index

1996

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

V A Miller is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, pharmacotherapy, and medicine.

Top concepts

Publications per year

1996–1999

3

Publications

3

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.

V A Miller, Francesca Benedetti, James R. Rigas et al. · Journal of Clinical Oncology · 1997 · 187 citations

Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid.

V A Miller, James R. Rigas, Francesca Benedetti et al. · PubMed · 1996 · 64 citations

, , +16

Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.

Lee M. Krug, Scott Grant, V A Miller et al. · PubMed · 1999 · 13 citations

Rows per page

1–3 of 3